StockComparison Logo
vs

EXFY vs CGTX

Comparison between Expensify Inc - Class A (EXFY, Company) and Cognition Therapeutics Inc (CGTX, Company).

EXFY is from the Technology sector, while CGTX is from the Healthcare sector.

5-Year PerformanceCGTX has outperformed EXFY, delivering a return of -38.2% compared to -54.3%

EXFY vs CGTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
EXFY
$107M
CGTX
$106M
Max Drawdown
EXFY
98.46%
Winner
CGTX
98.16%
Sharpe Ratio
EXFY
-0.85
Winner
CGTX
1.70
5Y Beta
EXFY
N/A
CGTX
1.92
Industry
EXFY
Software - Application
CGTX
Biotechnology
P/E Ratio
Winner
EXFY
-6.34
CGTX
-2.51
Debt to Equity
EXFY
0.00%
CGTX
0.00%
Free Cash Flow Yield
Winner
EXFY
14.40%
CGTX
-19.05%
P/S Ratio
EXFY
0.80
CGTX
N/A
P/B Ratio
Winner
EXFY
0.81
CGTX
3.56

EXFY vs CGTX - Historical Returns

Returns include dividend reinvestment.

1M
EXFY
+2.68%
Winner
CGTX
+6.25%
3M
EXFY
+12.75%
Winner
CGTX
+28.30%
6M
EXFY
-29.01%
Winner
CGTX
-22.73%
1Y
EXFY
-49.78%
Winner
CGTX
+342.13%
5Y(CAGR)
EXFY
-54.31%
Winner
CGTX
-38.20%
Max(CAGR)
EXFY
-54.31%
Winner
CGTX
-38.20%

EXFY vs CGTX - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearEXFYCGTX
2026-20.69%-7.48%
2025-56.86%+86.70%
2024+36.73%-63.85%
2023-71.21%-9.76%
2022-78.13%-66.40%
2021+7.16%-50.51%

EXFY vs CGTX Drawdown Comparison

The maximum drawdown for EXFY was -98.46%, occurring on Mar 17, 2026. This drawdown has not yet recovered.

The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.

The current EXFY drawdown is -97.63%. The current CGTX drawdown is -89.52%.

RankEXFYCGTX
#1-98.46%
Nov 26, 2021 - Mar 17, 2026
-98.16%
Nov 9, 2021 - May 30, 2025
#2-10.04%
Nov 12, 2021 - Nov 24, 2021
-6.81%
Oct 8, 2021 - Nov 9, 2021

Correlation

Correlation between EXFY and CGTX is 0.86 which considered as a strong positive correlation - the stocks tend to move together.

0.86
-101

Select Stocks to Compare